Literature DB >> 5002979

[Evaluation of the prolonged treatment of patients with the adult type of diabetes with glibenclamide (HB 419)].

C R Aiello, D Turner, L Schwarzstein, R E Adrián, E A De Turner, N J Aparicio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5002979     DOI： 10.1007/bf01550904

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN： 0001-5563


× No keyword cloud information.
  7 in total

1.  CLINICAL EVALUATION OF DRUGS FOR THE TREATMENT OF DIABETES.

Authors:  M J ALBRINK
Journal:  Diabetes       Date:  1964 Jul-Aug       Impact factor: 9.461

2.  [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].

Authors:  A Loubatières; M M Mariani; G Ribes; H de Malbosc; R Alric; J Chapal
Journal:  Arzneimittelforschung       Date:  1969-08

3.  [Acylaminoalkylbenzolsulfonylureas].

Authors:  H Weber; W Aumüller; K Muth; R Weyer; R Heerdt; E Fauland; A Bänder; W Pfaff; F H Schmidt; H Stork
Journal:  Arzneimittelforschung       Date:  1969-08

4.  [Acylaminoalkylbenzolsulfonylaminopyrimidines as blood sugar decreasing substances].

Authors:  R Heerdt; M Hübner; E Fauland; A Hagedorn; H Weber; W Aumüller; K Muth; R Weyer; F H Schmidt; H Stork
Journal:  Arzneimittelforschung       Date:  1969-08

5.  [Tolerance test of HB 419 in animal experiments].

Authors:  G Hebold; J Scholz; E Schütz; H Czerwek; R Brunk
Journal:  Arzneimittelforschung       Date:  1969-08

6.  [Pharmacology of HB 419, a new strongly effective oral antidiabetic].

Authors:  A Bänder; W Pfaff; F H Schmidt; H Stork; H G Schröder
Journal:  Arzneimittelforschung       Date:  1969-08

7.  [Acylaminoalkylbenzolsulfonylsemicarbazides as blood sugar decreasing substances].

Authors:  W Aumüller; E Fauland; A Hagedorn; R Heerdt; M Hübner; K Muth; H Weber; R Weyer; A Bänder; W Pfaff; F H Schmidt; H Stork
Journal:  Arzneimittelforschung       Date:  1969-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.